Blog

This year, six of Pacific Neuroscience Institute’s physicians were included in Los Angeles Magazine’s April 2021 roster of “L.A.’s Top Doctors.” The results were based on a Los Angeles Magazine survey that asked physicians throughout Los Angeles County to identify the doctors they considered to be at the...

Now twenty-one years in remission from a pituitary adenoma tumor, Sharmyn McGraw, patient advocate, author, artist, and so much more, talks about the pivotal role of Cushing’s disease in her life. From dyslexia to writer and everything in between. Dealing with a life threatening disease,...

By Rex Hoffman, MD, Chief Medical Officer, SoCal Clinical Institutes and Chief Medical Officer, Providence Holy Cross Medical Center April 1, 2021 – I am pleased to announce that Santosh Kesari, MD, PhD, has been named regional medical director of Southern California’s Research Clinical Institute....

March is National Multiple Sclerosis Awareness month. When the COVID-19 pandemic first emerged, there were many questions about how persons with Multiple Sclerosis (MS) would be affected.  Now a year later, we have answers to some of those questions, and other issues that have yet...

Nature-themed visual experience and psilocybin therapy used for treatment of alcohol use disorder SANTA MONICA, Calif., March 18, 2021— Pacific Neuroscience Institute (PNI) has launched its first psychedelic-assisted clinical trial and begun participant enrollment. The Visual Healing® study is a collaboration among PNI, award-winning filmmaker...

Cancer takes a toll on the mind, too, no matter what organ system it affects. Dr. Shanthi Gowrinathan has seen all of these things. She’s the Director of Psycho-Oncology at PNI, and she specializes in the mental health of cancer patients.

A South Bay man survives a life-threatening brain aneurysm thanks to a rapid medical response at Providence Little Company Medical Center in Torrance, California. Charles Demachy, a local SoCal plant nursery owner, remembers the headache most of all. It was crushing and “weird,” he says....

PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved.  We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...

New Studies EpicentRx Beta-Prime: A Phase I, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects with Refractory Solid Tumors (NCT04673942) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade...

Meet Sheena Reddy: A woman honors her mother’s fight against glioblastoma cancer while helping others.